A new case study published in Cureus by Saami Khalifian, MD; Alec D. McCarthy, MD; and Steven Yoelin, MD, examines the efficacy and safety of an injectable therapy for treating neck wrinkles and skin laxity. This therapy combines hyperdiluted calcium hydroxylapatite (CaHA), platelet-rich plasma (PRP), and hyaluronidase.
Two patients with moderate neck wrinkles and skin laxity received the treatment and were evaluated several months later.
The study found that a single treatment with the combined therapy improved skin texture and laxity.
The inclusion of PRP and hyaluronidase aimed to enhance the regenerative effects of CaHA. PRP is rich in growth factors that stimulate collagen production and regeneration, while hyaluronidase breaks down hyaluronic acid, promoting better diffusion and even product dispersion.
The findings from these cases provide preliminary evidence supporting the safety and efficacy of this innovative combination therapy for addressing neck wrinkles and laxity.
According to the researchers, this is the first documented instance of using CaHA in conjunction with hyaluronidase and PRP for skin priming.
Further investigations are needed to explore the application of this treatment for other anatomical regions and to clarify the role of each injected component.
Read complete findings at Cureus
More from The Blog
AmSpa Names 25 Distinguished Women in Medical Aesthetics 2025: Industry Leaders Recognized at WALC Conference
News provided by American Med Spa Association, LLC Aug 06, 2025, 09:00 ETThe American Med Spa Association (AmSpa) has unveiled its prestigious list of Distinguished Women in Medical Aesthetics 2025, honoring 25 exceptional leaders who exemplify excellence,...
The Legal Facelift: How to Build, Run, and Transition a Compliant Med Spa – Part I
In recent years, medical spas – commonly known as med spas – have surged in popularity, blending the clinical precision of medical procedures with the relaxing environment of traditional day spas. The demand for non-invasive medical aesthetic treatments like Botox,...
Obagi’s Skin Empire Just Bought Its Way Into Injectables — What That Means for Medspas
On July 23, 2025, Waldencast plc—parent company of Obagi Medical—acquired Novaestiq Corp. This deal gives Obagi U.S. rights to the global Saypha® line of hyaluronic acid (HA) fillers, which will be launched as Saypha ChIQ™ and MagIQ™ under the Obagi Medical brand....
The Florida “Shedspa” Story: Let’s Call This What It Really Is
Have you seen this story: A 50-year-old Florida woman named Rosa Mena was arrested after police say she was running an "unlicensed medical spa" in a shed in her backyard in Port St. Lucie. A victim experienced facial paralysis following a botched Botox injection she...
